Open Actively Recruiting

Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidS

About

Brief Summary

The purpose of this clinical trial is to compare two standard of care non-surgical treatments for hemorrhoidal bleeding: hemorrhoidal artery embolization (HAE) versus rubber band ligation (RBL). Directly comparing these two methods may help to clarify which treatment is better for controlling hemorrhoidal bleeding, reducing symptoms, and improving patients' quality of life.

HAE is a standard minimally invasive procedure to put tiny particles or coils into the blood vessel that feeds a hemorrhoid to block the blood flow (embolization). This involves using a catheter inserted into an artery, using twilight (conscious) sedation.

RBL is a standard procedure that involves using small rubber bands around the base of the hemorrhoids to cut off blood flow, causing it to shrink or shrivel.

Primary Purpose
The main objective of the intervention(s) being evaluated by the clinical trial. Learn more
Treatment
Study Type
The nature of the investigation or investigational use for which clinical study information is being submitted. Learn more
Interventional
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
89 Years

Inclusion Criteria:

  • Age ≥ 18 years and less than 90 years.
  • Ability to provide written informed consent.
  • Documented clinical history of chronic bleeding from internal hemorrhoids.
  • Documented presence of Goligher grade II-III internal hemorrhoids.
  • Failed conservative treatment for bleeding hemorrhoids (e.g. fiber supplementation, topical ointments and creams, dietary modifications, stool softeners, warm baths).
  • Able to comply with all treatments and protocol follow-up visits, in the opinion of the PI's.

Exclusion Criteria:

  • Moderate loss of kidney function, defined as estimated glomerular filtration rate of less than 45 mL/min.
  • Significant arterial atherosclerosis that would limit selective angiography.
  • Known alternative causes of GI bleeding.
  • Allergy to iodinated contrast agents.
  • Active infection or malignancy.
  • Pregnancy.
  • Active nicotine use within the last 12 months.
  • Portal hypertension/rectal varices.
  • Uncorrectable coagulopathy (INR > 2; Platelet count <100,000; PTT > 40 sec).
  • Findings on baseline CTA that adversely affect treatment, based on PI's clinical judgment, including but not limited to stenosis, occlusion, or hypoplasia of the superior and/or middle rectal arteries.
Study Stats
Protocol No.
25-2437
Category
GI Disorders
Principal Investigator
Jessica K. Stewart, MD
Jessica K. Stewart, MD
Interventional Radiology
Jessica K. Stewart, MD
Contact
  • Aniket Joglekar
Location
  • UCLA Calabasas
  • UCLA North Hollywood
  • UCLA Santa Clarita
  • UCLA Santa Monica
  • UCLA Westwood
For Providers
NCT No.
NCT07559630
For detailed technical eligibility, visit ClinicalTrials.gov.